Description
Retatrutide · Cagrilintide Blend combines the triple-receptor incretin agonist with a long-acting amylin analogue in a single co-lyophilized vial.
This four-pathway pairing (GIP, GLP-1, glucagon, amylin) represents the outer frontier of combination metabolic research protocols.
Format & handling
Supplied as a lyophilized powder in a sealed, batch-stamped vial. Store sealed at −20 °C protected from light. For laboratory work, reconstitute with bacteriostatic water shortly before use and refrigerate any working solution at 2–8 °C.
For laboratory research use only — not for human or veterinary use. The summary above describes published research for scientific context and makes no claims about this product.
